Skip to main content

Table 4 Migraine attacks with use of two or more doses, rescue medication, and severity of headache at the time of drug intake

From: A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine

 

ITT (n = 125)

p

Frovatriptan (n = 357)

Rizatriptan (n = 362)

Use of 2 doses of study medication

110 (31)

122 (34)

NS

Use of >2 doses of study medication

67 (19)

74 (20)

NS

Use of rescue medication

71 (20)

59 (16)

NS

Severity of headache at study drug intake

 Mild

76 (21)

93 (25)

NS

 Moderate

203 (57)

201 (56)

NS

 Severe

78 (22)

68 (19)

NS

  1. Data are shown for the intention-to-treat population and reported as absolute (n) and relative (%) frequency. p refer to the statistical significance of the difference between the two treatment groups